Elevance Health Files 8-K on Financial Condition, Operations

TL;DR

**Elevance Health just dropped an 8-K with fresh financials, time to check their numbers!**

AI Summary

Elevance Health, Inc. filed an 8-K on January 24, 2024, to report its results of operations and financial condition, along with financial statements and exhibits. This filing, under SEC File Number 001-16751, indicates that the company is providing updated financial information to the public. For investors, this matters because it provides the latest official financial health check, which can influence stock price and future investment decisions.

Why It Matters

This filing provides investors with the most current financial performance data for Elevance Health, Inc., which is crucial for evaluating the company's health and making informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any specific new risks or adverse events.

Analyst Insight

A smart investor would review the detailed financial statements and exhibits referenced in this 8-K once they become available to understand Elevance Health's current financial performance and operational health.

Key Numbers

• 001-16751 — SEC File Number (identifies Elevance Health's registration with the SEC)
• 20240124 — Filing Date (the date the 8-K was filed with the SEC)

Key Players & Entities

• Elevance Health, Inc. (company) — the registrant filing the 8-K
• 001-16751 (dollar_amount) — the Commission File Number for Elevance Health, Inc.
• January 24, 2024 (date) — the date of the earliest event reported and filing date
• NYSE (company) — the exchange where Elevance Health's Common Stock is registered
• ELV (company) — the trading symbol for Elevance Health's Common Stock

FAQ

From the Filing

0001193125-24-013498.txt : 20240124 0001193125-24-013498.hdr.sgml : 20240124 20240124060459 ACCESSION NUMBER: 0001193125-24-013498 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240124 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 24554154 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 d736006d8k.htm 8-K 8-K false 0001156039 0001156039 2024-01-24 2024-01-24     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 24, 2024 Date of Report (Date of earliest event reported)     Elevance Health, Inc. (Exact name of registrant as specified in its charter)       Indiana   001-16751   35-2145715 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (I.R.S. Employer Identification Number)   220 Virginia Ave Indianapolis , IN 46204 (Address of principal executive offices and zip code) (833) 401-1577 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol   Name of each exchange on which registered Common Stock, Par Value $0.01   ELV   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       Item 2.02 Results of Operations and Financial Condition. On January 24, 2024, Elevance Health, Inc. issued a press release reporting its financial results for the quarter ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the